Eloxx Pharmaceuticals Stock Forecast
NASDAQ: ELOXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 9, 2:37 PM ET
ELOX analyst consensus
Consensus (4 analysts)
none
Avg. price target
$38.25+180.98%
- Strong buy 0
- Buy 4
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 4 Wall Street analysts covering Eloxx Pharmaceuticals (2026-10-09), 4 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $38.25, with a high estimate of $43.00 and a low estimate of $32.00. The average target implies upside of 181.0% from the current price of $13.61.
The spread between the highest and lowest targets is 34.4%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for ELOX.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 4 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-09.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $32.00 | +135.07% |
| Average target | $38.25 | +180.98% |
| High target | $43.00 | +215.87% |